Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.48%
#2 Ocean Protocol Ocean Protocol +21.53%
#3 Geodnet Geodnet +15.00%
#4 Audiera Audiera +11.80%
#5 Cysic Cysic +8.78%
#6 KUB Coin KUB Coin +8.63%
#7 Arowana Arowana +7.85%
#8 DexNet DexNet +7.78%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.66%
#10 Rollbit Coin Rollbit Coin +6.27%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Clasificación en acciones #32244
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Precio por acción
$4.65
Última sincronización: 2024-07-24
Capitalización bursátil
$10.63M
Cambio (1 día)
6.66%
Cambio (1 año)
0.00%
País
AU
Comercio Medlab Clinical Limited (MDC)

Categoría

Healthcare
Historial del precio de la acción de Medlab Clinical Limited (MDC)
Precio más alto de cierre: $4.65 el 2024-07-01

Precio más bajo de cierre: $20.06 el 2015-07-01
Historial del precio de la acción de Medlab Clinical Limited desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 5.52%
2023 -8.38%
2022 -69.42%
2021 -45.35%
2020 -15.13%
2019 -18.05%
2018 -52.21%
2017 -8.72%
2016 360.38%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.17 -36.90%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.06K -6.61%
KR